异动解读|麦克森药物批发盘中上涨3.35%,财报超预期并获投行上调目标价

行情直击
Nov 05

11月5日,麦克森药物批发盘中上涨3.35%,报1092.185美元/股,成交额1.02亿美元。

此次异动的直接催化来自公司最新财报超预期且全年指引上调,叠加投行将目标价从1070美元上调至1200美元,进一步提振市场情绪。

公司最新财季调整后每股收益11.68美元,高于市场预期的10.72美元;营收1109.6亿美元,高于预期的1099.0亿美元;并将全年调整后每股收益指引上调至45.60至46.40美元,亦高于市场预期的44.65美元。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10